Wells Fargo
IRON icon

Wells Fargo’s Disc Medicine IRON Stock Holding History

Wells Fargo’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Buy
28,924
+14,234
+97% +$978K ﹤0.01% 3560
2026
Q1 		$939K Sell
14,690
-18,575
-56% -$1.29M ﹤0.01% 3774
2025
Q4 		$2.64M Buy
33,265
+6,210
+23% +$525K ﹤0.01% 3219
2025
Q3 		$1.79M Buy
27,055
+4,594
+20% +$273K ﹤0.01% 3392
2025
Q2 		$1.19M Sell
22,461
-375
-2% -$17.6K ﹤0.01% 3588
2025
Q1 		$1.13M Buy
22,836
+2,058
+10% +$114K ﹤0.01% 3577
2024
Q4 		$1.32M Buy
20,778
+7,808
+60% +$452K ﹤0.01% 3509
2024
Q3 		$637K Buy
12,970
+1,224
+10% +$57.5K ﹤0.01% 3839
2024
Q2 		$529K Buy
11,746
+3,553
+43% +$121K ﹤0.01% 3877
2024
Q1 		$510K Buy
8,193
+5,622
+219% +$365K ﹤0.01% 3878
2023
Q4 		$149K Sell
2,571
-10,719
-81% -$549K ﹤0.01% 4652
2023
Q3 		$624K Buy
13,290
+10,091
+315% +$505K ﹤0.01% 3624
2023
Q2 		$142K Buy
3,199
+3,173
+12,204% +$113K ﹤0.01% 4796
2023
Q1 		$551 Buy
+26
New +$579 ﹤0.01% 6530
2022
Q4 		– Sell
-5
Closed – – 7588
2022
Q3 		$0 Hold
5
– – ﹤0.01% 6989
2022
Q2 		$0 Sell
5
-1,585
-100% -$70.1K ﹤0.01% 7136
2022
Q1 		$66K Buy
1,590
+912
+135% +$47.8K ﹤0.01% 5524
2021
Q4 		$59K Buy
678
+98
+17% +$9.61K ﹤0.01% 5884
2021
Q3 		$70K Sell
580
-269
-32% -$36.8K ﹤0.01% 5513
2021
Q2 		$165K Buy
849
+842
+12,029% +$277K ﹤0.01% 5108
2021
Q1 		$3K Buy
+7
New +$3.12K ﹤0.01% 6584

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wells Fargo's IRON Position: Q2 2026 in Review

Wells Fargo increased its Disc Medicine (IRON) stake by 97% in Q2 2026, buying an estimated $978K and bringing the position to 28,924 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3560.

Wells Fargo first reported a position in IRON in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.64M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Wells Fargo held 28,924 shares of Disc Medicine worth $2.12M as of Q2 2026.
  • Wells Fargo bought 14,234 Disc Medicine shares in Q2 2026, an estimated $978K.
  • Disc Medicine made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3560 holding.
  • Wells Fargo first reported a position in Disc Medicine in Q1 2021 and has held it in 21 quarters since.
  • Wells Fargo's Disc Medicine position peaked at $2.64M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.